Partial purification and characterization of particulate guanylate cyclase from rat liver after solubilization with trypsin
- PMID: 6136535
Partial purification and characterization of particulate guanylate cyclase from rat liver after solubilization with trypsin
Abstract
Guanylate cyclase from 105,000 X g particulate fractions of rat liver homogenates (20 pmoles of cyclic GMP formed/min/mg protein) was solubilized in the absence of detergents by incubating fractions 12 min at 37 degrees with 5 ug/ml trypsin. Optimal solubilization was dependent upon trypsin and particulate preparation concentrations. Virtually no activation of particulate guanylate cyclase was observed at any time point or trypsin concentration tested. Guanylate cyclase solubilized with trypsin was purified about 500-fold (9.4 nmoles/min/mg protein) using ammonium sulfate precipitation, GTP-affinity chromatography, and preparative polyacrylamide gel electrophoresis. Activity eluted as a single peak on Sepadex G-200 (Stokes radius = 40 A) and migrated as a single peak on sucrose density gradients (S20,w = 4.6). Thus, the tryptic fragment was estimated to be about 80,000 daltons (Mr) with a frictional ratio (f/fo) of 1.4. These partially purified preparations exhibited linear double reciprocal plots with Mn-GTP and Hill coefficients of 1.0. This is in contrast to the crude membrane-associated enzyme which had a Hill co-efficient of 1.5. Membrane-bound and trypsin-solubilized guanylate cyclase were activated 3- and 4-fold with nitric oxide and were inhibited with 1mM cystamine. Cystamine inhibition could be partially reversed with 7.5 mM dithiothreitol. These studies indicate that particulate guanylate cyclase solubilized by limited proteolysis is amenable to purification by "classical" chromatographic techniques. The partially purified fragment contains the catalytic site, the site for nitric oxide activation, and at least one sulfhydryl group required for activity.
Similar articles
-
Purified guanylate cyclase: characterization, iodination and preparation of monoclonal antibodies.J Cyclic Nucleotide Res. 1980;6(4):283-96. J Cyclic Nucleotide Res. 1980. PMID: 6110682
-
Localization of particulate guanylate cyclase in plasma membranes and microsomes of rat liver.J Biol Chem. 1975 Jun 25;250(12):4810-7. J Biol Chem. 1975. PMID: 237912
-
Guanylate cyclase: purification, properties, free radical activation, radiolabeling, and preparation of hybridoma antibodies.Adv Cyclic Nucleotide Res. 1981;14:229-39. Adv Cyclic Nucleotide Res. 1981. PMID: 6116385
-
[Nitric oxide. The role of guanylate cyclase in its physiological effects].Vopr Med Khim. 2002 Jan-Feb;48(1):4-30. Vopr Med Khim. 2002. PMID: 12068497 Review. Russian.
-
Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.Biochemistry (Mosc). 1998 Jul;63(7):794-801. Biochemistry (Mosc). 1998. PMID: 9721331 Review.
Cited by
-
Multilimbed membrane guanylate cyclase signaling system, evolutionary ladder.Front Mol Neurosci. 2023 Jan 5;15:1022771. doi: 10.3389/fnmol.2022.1022771. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36683846 Free PMC article. Review.
-
Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liver.Gut. 1997 Jan;40(1):145-50. doi: 10.1136/gut.40.1.145. Gut. 1997. PMID: 9155593 Free PMC article.
-
Intestinal receptor for heat-stable enterotoxin of Escherichia coli is tightly coupled to a novel form of particulate guanylate cyclase.Infect Immun. 1986 Jan;51(1):320-6. doi: 10.1128/iai.51.1.320-326.1986. Infect Immun. 1986. PMID: 2867046 Free PMC article.
-
ACTH-Modulated Membrane Guanylate Cyclase Signaling System: Origin and Creation.Front Mol Neurosci. 2022 Aug 9;15:929396. doi: 10.3389/fnmol.2022.929396. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36017080 Free PMC article. Review.
-
Evolution of the membrane guanylate cyclase transduction system.Mol Cell Biochem. 2002 Jan;230(1-2):3-30. Mol Cell Biochem. 2002. PMID: 11952094 Review.